Bumetanide - Oritavancin diphosphate - 1

section name header

Y-Site Injection Compatibility (1:1 Mixture)

(Mfr: HOS)(Conc: 0.1 mg/mL^a)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mL^a)

Remarks:

Haze forms immediately with precipitate after 30 min

Ref:

²⁹²⁸